Thomas Laughren
Psychiatry · Rockville, MDNPI 1184927212
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $278,611 of the $283,351 with a category attached, or 98.3%. 22 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 26.2% of the total. Reporting peaked in 2020 at $74,032 and has fallen 77.3% since, to $16,800 in 2025. Among psychiatry clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $1523.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$74K
- Janssen Research & Development, LLC$55K
- Bioxcel Therapeutics, Inc.$36K
- Greenwich Biosciences, Inc.$22K
- Novartis$21K
- Neurocrine Biosciences, Inc.$17K
- plus $58K from 16 others
Across 18 payments — averaging $1307.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Supernus Pharmaceuticals, Inc.$13K
- Biogen$8K
- Arbor Pharmaceuticals, Inc.$2K
- H. Lundbeck A S$875
What the payments were for
- Consulting fees$278,61198%
- Travel & lodging$3,9631%
- Food & beverage$7780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 39 | $74,250 |
| Janssen Research & Development, LLC | 55 | $55,138 |
| Bioxcel Therapeutics, Inc. | 7 | $36,375 |
| Greenwich Biosciences, Inc. | 10 | $22,205 |
| Novartis | 9 | $20,915 |
| Neurocrine Biosciences, Inc. | 15 | $16,625 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $10,545 |
| Jazz Pharmaceuticals Inc. | 12 | $9,350 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $7,000 |
| Impel Pharmaceuticals Inc. | 3 | $4,625 |
| Biogen | 3 | $3,978 |
| Supernus Pharmaceuticals, Inc. | 3 | $3,875 |
| Janssen Scientific Affairs, LLC | 2 | $3,720 |
| Harmony Biosciences LLC | 3 | $2,500 |
| Janssen Global Services, LLC | 1 | $2,500 |
| GW Research Limited | 3 | $2,500 |
| Merck | 2 | $2,125 |
| Roche Products Limited | 1 | $1,125 |
| Noven Therapeutics, LLC | 1 | $1,125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $1,125 |
| F. Hoffmann-la Roche AG | 1 | $1,000 |
| Alkermes, Inc. | 1 | $750 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$283,351 in reported general payments places this provider in the 95th percentile of 851 psychiatry providers in Maryland.
Other psychiatry in Rockville
- Jay BronderRockville$18K
- Steven IsraelRockville$15K
- Andreea SeiceanRockville$15K
- Harry Westley ClarkRockville$7K
- John VaethBaltimore$2.1M
- Scott AaronsonBaltimore$334K
- Jamal FawazHagerstown$321K
- Adam RothAnnapolis$210K
- Robert LehmanBaltimore$140K
- Karen AndersonBaltimore$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.